Navigation Links
Hologic Announces First Quarter Fiscal 2008 Operating Results
Date:1/31/2008

bilities 49,357 7,791

Total long term liabilities 3,038,486 82,014

STOCKHOLDERS' EQUITY:

Common stock, $.01 par value-Authorized -

300,000 shares Issued - 127,362 and 55,150

shares, respectively 1,274 551

Capital in excess of par value 4,794,813 634,029

Retained earnings (190,635) 168,453

Accumulated other comprehensive income 5,723 4,123

Treasury stock, 107 and 90 shares,

respectively, at cost (1,433) (1,433)

Total stockholders' equity 4,609,742 805,723

$7,898,628 $1,066,349

HOLOGIC, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)

Three Months Ended

December 29, December 30,

2007 2006

REVENUES $371,445 $163,212

COSTS AND EXPENSES (1):

Cost of revenues 183,455 85,785

Cost of revenues - amortization of intangible

assets 20,155 3,072

Research and development 20,147 10,816

Selling and marketing 56,986 20,883

General and administrative 34,334 14,731

Amortization of acquired intangible assets 6,249 1,408

Impairment of acquired intangible assets 2,900
'/>"/>

SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
2. Hologic to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ch.,Nov.23/PRNewswire-FirstCall/--NeogenCorporatio...,Ph.D.,waselectedtoNeogen,sBoardofDirectorsattheco...owderhasmorethan40yearsofexperienceinthefood,agric...unctprofessorofagriculturaleconomicsatVirginiaTech...nitedStateschiefagriculturenegotiatorwiththerankof...
(Date:11/23/2009)...,Nov.23/PRNewswire/-InimexPharmaceuticals,Inc.anno...itsPresidentandCEO. ,, Abramsbringsmorethan25ye....Heisaco-inventorofthenuclearmedicineimagingagent,...,plcwherehewasManager,BiomedicalResearchWorldwide....,BCandwasPresidentandCEOfrom1996to2006.AnorMEDdisc...
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--CornerstoneTherapeut...panyfocusedonacquiring,developingandcommercializin...elatedmarkets,todayannouncedthatCraigA.Collard,Pre...rporateoverviewatthe21stAnnualPiperJaffrayHealthCa...TheNewYorkPalaceHotelinNewYorkCity. ,, Aliveaud...
(Date:11/20/2009)...GO, Nov. 20 Veridiam (www.veridiam...-size company category at the 2009 Workplace Excel...Diego Society for Human Resources Management and r...s practices. ,, Veridiam was one of nine winner...companies, honored at the recent awards ceremony. ...
Breaking Biology Technology:Richard T. Crowder Joins Neogen's Board of Directors 2Inimex Announces Appointment of New CEO 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2
...GA, ON, Oct. 11 /PRNewswire-FirstCall/ - YM BioSci...logy company that identifies, develops,and commerc...wide, today,advised that its Annual Meeting of Sha...t 4:00pm at the Gallery of the TSX Broadcast & Con...t West, Toronto, Ontario. The items for considera...
... Oppose Proposal to Kill Human Embryos for Researc...ference President and Chief Executive Officer Sist...atement today regarding the formation of the,ballo...In order to protect human life at its most vulnera...ated, that seeks to clone and/or kill,human embryo...
...zerland, October 11 The young Swiss biotech,enter... Michel Klein, one,of the world,s most renowned va...ice President of Science & Technology of the Avent...ship of the scientific sector of,vaccine developme...as,access to an outstanding network across one of ...
Other Biology Technology:YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS 2YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS 3Prof. Michel Klein Becomes Chief Scientific Officer at AMVAC 2
(Date:11/22/2009)...ildren exposed prenatally to tobacco smoke and dur...k for ADHD, according to research done at Cincinna...dy estimates that up to 35 percent of ADHD cases i...educed by eliminating both of these environmental ... children , "Tobacco and lead exposure each hav...
(Date:11/22/2009)...ited gene deletion can increase the likelihood of ...antation, an international team of researchers rep...ature Genetics . When the gene, called UGT2B17, is...e recipient,s, transplants have a significantly gr...-versus-host disease, in which immune cells from t...
(Date:11/22/2009)...e Brain Research Centre, a partnership of the Univ... Vancouver Coastal Health Research Institute, have...which brain cells die following a stroke, as well ...ults of the study were recently published online i...brain cells continue to die even after blood flow ...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4New understanding about mechanism for cell death after stroke leads to possible therapy 2Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 1Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 2Survey finds just 40 percent of adults absolutely certain they will get H1N1 vaccine 58762 1Survey finds just 40 percent of adults absolutely certain they will get H1N1 vaccine 58762 2Survey finds just 40 percent of adults absolutely certain they will get H1N1 vaccine 58762 3Survey finds just 40 percent of adults absolutely certain they will get H1N1 vaccine 58762 4Cholesterol necessary for brain development 10237 1
...ard H. Ebright and his collaborators have resolved...ental life process that was the subject of the 200...e first step in the process cells employ to read a...es. Transcription is carried out by a molecular ma...n RNA copy of the information in DNA. , Two pa...
...esearchers have developed two new technologies for...rst patent-pending technology provides a way for r...aboratory are responding to an anti-cancer drug. T...s at once -- allows for the simultaneous testing o...g on different kinds of cells taken from the body....
...s at Chicago study has been stopped early due to p...ision of men reduces their risk of acquiring HIV d...e study,s independent Data Safety and Monitoring B... on the board,s review, the National Institutes of...men enrolled in the study who remain uncircumcised...
Other Biology News:Nanotech tools yield DNA transcription breakthrough 2Nanotech tools yield DNA transcription breakthrough 3Nanotech tools yield DNA transcription breakthrough 4Chemical tests of cell growth enter third dimension 2Chemical tests of cell growth enter third dimension 3Male circumcision reduces HIV risk, study stopped early 2Male circumcision reduces HIV risk, study stopped early 3
...t not structural information the AXIMA-LNR linear ...high throughput QA/QC applications and for high pe...lude oligonucleotide QA/QC, SNP analysis, protein ...d polymer analysis, with the ability to run up to ...
RAOEC (R304-05) from European Collection of Cell Cultures (ECACC)
...modular instrument which can be used for a variety...lar, Transducer & Multi-channel Isolated Amplifica...L900D) forms the heart of every NeuroLog System. ...ing within the case allows signals to be passed be...
Mouse Anti-Drosophila Yan Drosophila protein Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: